Shares of Sun Pharmaceutical Industries gained 2 percent intraday Thursday on short covering after the US health regulator issued nine observations for Halol plant. The recovery in share price may also be on hopes that the company...

Global IT services major - Virtusa Corporation which had a majority interest in Polaris, plans to sell 18.86 lakh shares or 1.86 percent in the company via an offer for sale (OFS) at a 40-percent discount to the acquisition price ...

Credit Suisse says delinking pension fund should pave way for Thyssenkrupp JV, which could take 6-12 months to materialise. The brokerage firm maintains outperform rating with target unchanged at Rs 515 per share.

Healthcare major Sun Pharmaceutical Industries shares plunged more than 6 percent intraday Wednesday on US Food and Drug Administration (USFDA) concerns. According to IIFL, the US health regulator has issued 14-page 483 observatio...